SCHEMBL819979

SCHEMBL819979

N#CC1CCC(C#N)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL820325 0.86
SCHEMBL820894 0.86
SCHEMBL15139927 0.86
SCHEMBL15137361 0.86
SCHEMBL15139926 0.86
SCHEMBL6618 0.84
SCHEMBL28823871 0.84
SCHEMBL1164553 0.84 KDM4E (0.34)
SCHEMBL29771365 0.84
SCHEMBL45941 0.84 KDM4E (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2382241-B1 POLYMERS FUNCTIONALIZED WITH POLYCYANO COMPOUNDS BRIDGESTONE CORP (JP) 2016-11-23 EP claimed
US-8785566-B2 Polymers functionalized with polycyano compounds BRIDGESTONE CORPORATION (JP) 2014-07-22 US claimed
EP-0638080-A4 7-DISUBSTITUTED-METHYL-4-OXO-3H -,5H --PYRROLO 3,2-d -]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME. BIOCRYST PHARM INC (US) 1995-08-23 EP claimed
EP-0500653-A4 INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE BIOCRYST INC (US) 1995-08-23 EP claimed
EP-0638080-A1 7-DISUBSTITUTED-METHYL-4-OXO-3H -,5H --PYRROLO 3,2-d -]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME BIOCRYST PHARMACEUTICALS, INC. (US) 1995-02-15 EP claimed
WO-1993021187-A1 7-DISUBSTITUTED-METHYL-4-OXO-3H^_,5H^_-PYRROLO[3,2-d^_]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME BIOCRYST PHARMACEUTICALS, INC. (US) 1993-10-28 WO claimed
EP-0500653-A1 INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE BIOCRYST PHARMACEUTICALS INC. (US) 1992-09-02 EP claimed
WO-1991006548-A1 INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE BIOCRYST, INC. (US) 1991-05-16 WO claimed
US-4215068-A Preparation of 1,3-dicyanocyclopentane GULF RESEARCH & DEVELOPMENT COMPANY (US) 1980-07-29 US claimed
EP-3184171-B1 PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS CHEVRON PHILLIPS CHEMICAL CO LP (US) 2019-03-20 EP disclosed
US-10144752-B2 Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2018-12-04 US disclosed
US-10081688-B2 Polymers functionalized with polycyano compounds BRIDGESTONE CORPORATION (JP) 2018-09-25 US disclosed
EP-3373375-A1 USE OF ALIPHATIC DINITRILES IN ELECTROCHEMICAL CELLS FOR REDUCING METAL LEACHING BASF SE (DE) 2018-09-12 EP disclosed
US-20170305945-A1 Phosphinyl Amidine Compounds, Metal Complexes, Catalyst Systems, and Their Use to Oligomerize or Polymerize Olefins CHEVRON PHILLIPS CHEMICAL COMPANY LP 2017-10-26 US disclosed
US-5189039-A 7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo[3,2d]pyrimidine and pharmaceutical uses and compositions containing the same BIOCRYST, INC. (US) 1993-02-23 US disclosed
EP-0500653-A1 INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE BIOCRYST PHARMACEUTICALS INC. (US) 1992-09-02 EP disclosed
WO-1991006548-A1 INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE BIOCRYST, INC. (US) 1991-05-16 WO disclosed
US-4215068-A Preparation of 1,3-dicyanocyclopentane GULF RESEARCH & DEVELOPMENT COMPANY (US) 1980-07-29 US disclosed
US-4215068-A Preparation of 1,3-dicyanocyclopentane GULF RESEARCH & DEVELOPMENT COMPANY (US) 1980-07-29 US disclosed
US-4215068-A Preparation of 1,3-dicyanocyclopentane GULF RESEARCH & DEVELOPMENT COMPANY (US) 1980-07-29 US disclosed